Sanofi boosts Middle Eastern presence with Globalpharma stake
This article was originally published in Scrip
Executive Summary
Sanofi has acquired a 66% stake in a Middle Eastern generics company, Globalpharma, which under Sanofi's management will cover the United Arab Emirates, Saudi Arabia and Iraq.